These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30311860)

  • 1. Human Tissue-Engineered Model of Myocardial Ischemia-Reperfusion Injury.
    Chen T; Vunjak-Novakovic G
    Tissue Eng Part A; 2019 May; 25(9-10):711-724. PubMed ID: 30311860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cardiac progenitor cell activation and regeneration mechanisms: exploring a novel myocardial ischemia/reperfusion in vitro model.
    Sebastião MJ; Serra M; Pereira R; Palacios I; Gomes-Alves P; Alves PM
    Stem Cell Res Ther; 2019 Mar; 10(1):77. PubMed ID: 30845956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission.
    Canfield SG; Zaja I; Godshaw B; Twaroski D; Bai X; Bosnjak ZJ
    Anesth Analg; 2016 May; 122(5):1269-79. PubMed ID: 26991754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction.
    Acun A; Nguyen TD; Zorlutuna P
    Acta Biomater; 2019 Aug; 94():372-391. PubMed ID: 31146032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart.
    Pruefer D; Buerke U; Khalil M; Dahm M; Darius H; Oelert H; Buerke M
    J Thorac Cardiovasc Surg; 2002 Nov; 124(5):942-9. PubMed ID: 12407377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial ischemia/reperfusion injury: potential of TRPV1 agonists as cardioprotective agents.
    Vemula P; Gautam B; Abela GS; Wang DH
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):71-8. PubMed ID: 24304232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc and myocardial ischemia/reperfusion injury.
    Xu Z; Zhou J
    Biometals; 2013 Dec; 26(6):863-78. PubMed ID: 23982700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury.
    Liu J; Zhu H; Zheng Y; Xu Z; Li L; Tan T; Park KH; Hou J; Zhang C; Li D; Li R; Liu Z; Weisleder N; Zhu D; Lin P; Ma J
    J Mol Cell Cardiol; 2015 Mar; 80():10-19. PubMed ID: 25533937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Toll-like receptor 4 (TLR4) in cardiac ischaemic-reperfusion injury, cardioprotection and preconditioning.
    Lee SM; Hutchinson M; Saint DA
    Clin Exp Pharmacol Physiol; 2016 Sep; 43(9):864-71. PubMed ID: 27249055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pH paradox in ischemia-reperfusion injury to cardiac myocytes.
    Lemasters JJ; Bond JM; Chacon E; Harper IS; Kaplan SH; Ohata H; Trollinger DR; Herman B; Cascio WE
    EXS; 1996; 76():99-114. PubMed ID: 8805791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes.
    Blazeski A; Lowenthal J; Wang Y; Teuben R; Zhu R; Gerecht S; Tomaselli G; Tung L
    Tissue Eng Part A; 2019 May; 25(9-10):725-735. PubMed ID: 30520705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
    Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protection of oxyphenamone on myocardium against ischemia-reperfusion injury in rat heart].
    Fan LL; Teng J; Zhang RD; Zhao DY
    Yao Xue Xue Bao; 2005 Jun; 40(6):507-12. PubMed ID: 16144314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water-soluble acacetin prodrug confers significant cardioprotection against ischemia/reperfusion injury.
    Liu H; Yang L; Wu HJ; Chen KH; Lin F; Li G; Sun HY; Xiao GS; Wang Y; Li GR
    Sci Rep; 2016 Nov; 6():36435. PubMed ID: 27819271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.
    Nakamura T; Mizuno S; Matsumoto K; Sawa Y; Matsuda H; Nakamura T
    J Clin Invest; 2000 Dec; 106(12):1511-9. PubMed ID: 11120758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophiopogonin D Reduces Myocardial Ischemia-Reperfusion Injury via Upregulating CYP2J3/EETs in Rats.
    Huang X; Wang Y; Wang Y; Yang L; Wang J; Gao Y
    Cell Physiol Biochem; 2018; 49(4):1646-1658. PubMed ID: 30227401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.